Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain

No studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012,...

Full description

Bibliographic Details
Main Authors: Antonio Palazón-Bru, Miriam Calvo-Pérez, Pilar Rico-Ferreira, María Anunciación Freire-Ballesta, Vicente Francisco Gil-Guillén, María de los Ángeles Carbonell-Torregrosa
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:https://www.mdpi.com/1660-4601/18/15/8009
id doaj-d9970a32b21b4d40925704e69af15aaf
record_format Article
spelling doaj-d9970a32b21b4d40925704e69af15aaf2021-08-06T15:23:27ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-07-01188009800910.3390/ijerph18158009Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in SpainAntonio Palazón-Bru0Miriam Calvo-Pérez1Pilar Rico-Ferreira2María Anunciación Freire-Ballesta3Vicente Francisco Gil-Guillén4María de los Ángeles Carbonell-Torregrosa5Department of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, SpainPrimary Care Pharmacy Service, General University Hospital of Alicante, 03010 Alicante, SpainDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, SpainNo studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012, a PCS was implemented in Spain, and we designed a time series analysis (1978–2018) to assess its impact on emergency hospital admissions. Hospital admission rates were estimated between 1978 and 2018 each month using the Hospital Morbidity Survey in Spain (the number of urgent hospital admissions per 100,000 inhabitants). This was conducted for men, women and both and for all-cause, cardiovascular and respiratory hospital discharges. Life expectancy was obtained from the National Institute of Statistics. The copayment variable took a value of 0 before its implementation (pre-PCS: January 1978–June 2012) and 1 after that (post-PCS: July 2012–December 2018). ARIMA (Autoregressive Integrated Moving Average) (2,0,0)(1,0,0) models were estimated with two predictors (life expectancy and copayment implementation). Pharmaceutical copayment did not influence hospital admission rates (with <i>p</i>-values between 0.448 and 0.925) and there was even a reduction in the rates for most of the analyses performed. In conclusion, the PCS did not influence hospital admission rates. More studies are needed to design health policies that strike a balance between the amount contributed by the taxpayer and hospital admission rates.https://www.mdpi.com/1660-4601/18/15/8009pharmacycopaymenthealth expenditurescost controlhospitalizationinpatients
collection DOAJ
language English
format Article
sources DOAJ
author Antonio Palazón-Bru
Miriam Calvo-Pérez
Pilar Rico-Ferreira
María Anunciación Freire-Ballesta
Vicente Francisco Gil-Guillén
María de los Ángeles Carbonell-Torregrosa
spellingShingle Antonio Palazón-Bru
Miriam Calvo-Pérez
Pilar Rico-Ferreira
María Anunciación Freire-Ballesta
Vicente Francisco Gil-Guillén
María de los Ángeles Carbonell-Torregrosa
Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
International Journal of Environmental Research and Public Health
pharmacy
copayment
health expenditures
cost control
hospitalization
inpatients
author_facet Antonio Palazón-Bru
Miriam Calvo-Pérez
Pilar Rico-Ferreira
María Anunciación Freire-Ballesta
Vicente Francisco Gil-Guillén
María de los Ángeles Carbonell-Torregrosa
author_sort Antonio Palazón-Bru
title Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
title_short Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
title_full Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
title_fullStr Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
title_full_unstemmed Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain
title_sort influence of pharmaceutical copayment on emergency hospital admissions: a 1978–2018 time series analysis in spain
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1661-7827
1660-4601
publishDate 2021-07-01
description No studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012, a PCS was implemented in Spain, and we designed a time series analysis (1978–2018) to assess its impact on emergency hospital admissions. Hospital admission rates were estimated between 1978 and 2018 each month using the Hospital Morbidity Survey in Spain (the number of urgent hospital admissions per 100,000 inhabitants). This was conducted for men, women and both and for all-cause, cardiovascular and respiratory hospital discharges. Life expectancy was obtained from the National Institute of Statistics. The copayment variable took a value of 0 before its implementation (pre-PCS: January 1978–June 2012) and 1 after that (post-PCS: July 2012–December 2018). ARIMA (Autoregressive Integrated Moving Average) (2,0,0)(1,0,0) models were estimated with two predictors (life expectancy and copayment implementation). Pharmaceutical copayment did not influence hospital admission rates (with <i>p</i>-values between 0.448 and 0.925) and there was even a reduction in the rates for most of the analyses performed. In conclusion, the PCS did not influence hospital admission rates. More studies are needed to design health policies that strike a balance between the amount contributed by the taxpayer and hospital admission rates.
topic pharmacy
copayment
health expenditures
cost control
hospitalization
inpatients
url https://www.mdpi.com/1660-4601/18/15/8009
work_keys_str_mv AT antoniopalazonbru influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
AT miriamcalvoperez influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
AT pilarricoferreira influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
AT mariaanunciacionfreireballesta influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
AT vicentefranciscogilguillen influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
AT mariadelosangelescarbonelltorregrosa influenceofpharmaceuticalcopaymentonemergencyhospitaladmissionsa19782018timeseriesanalysisinspain
_version_ 1721218538422665216